No evidence of obstetrical adverse events after hyperimmune globulin application for primary cytomegalovirus infection in pregnancy: experience from a single centre

Archives of Gynecology and Obstetrics

Volumn 297, Issue 6, 2018, Pages 1389-1395

  Chiaie, Loredana Delle ^a   Neuberger, Patrick ^a   Vochem, Matthias ^a   Lihs, Angela ^a   Karck, Ulrich ^a   Enders, Martin ^b  

^a OLGAHOSPITAL   (Germany)

^b Laboratory Prof Gisela Enders and Colleagues   (Germany)

Author keywords

Antenatal; Cytomegalovirus; Hyperimmune globulin; Pregnancy; Prenatal; Treatment

Indexed keywords

HYPERIMMUNE GLOBULIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ADULT; AMNION FLUID; ANTIBODY SPECIFICITY; ARTICLE; BILATERAL HEARING LOSS; BIRTH; BIRTH WEIGHT; COHORT ANALYSIS; CONGENITAL CYTOMEGALOVIRUS INFECTION; CONTROLLED STUDY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DEVELOPMENTAL DELAY; DRUG EFFICACY; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEMALE; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; HEAD CIRCUMFERENCE; HUMAN; INFANT; LIVE BIRTH; MAJOR CLINICAL STUDY; MATERNAL INFECTION; MILD MOTORIC DELAY; MULTIPLE CYCLE TREATMENT; NAUSEA; PREGNANCY; PREGNANT WOMAN; PREMATURE LABOR; PRENATAL CARE; PRIMARY CYTOMEGALOVIRUS INFECTION; PRIMARY INFECTION; RETROSPECTIVE STUDY; SEROCONVERSION; SINGLETON PREGNANCY; TACHYCARDIA; TWIN PREGNANCY; URINE; VIRUS DETECTION;

EID: 85045043127     PISSN: 09320067     EISSN: 14320711     Source Type: Journal    
DOI: 10.1007/s00404-018-4703-y     Document Type: Article

References (18)

1. Dollard SC, Grosse SD, Ross DS (2007) New estimates of the prevalence of neurological and sensory sequelae and mortality associated with congenital cytomegalovirus infection. Rev Med Virol 17(5):355–363
2. Enders G, Daiminger A, Bäder U, Exler S, Enders M (2011) Intrauterine transmission and clinical outcome of 248 pregnancies with primary cytomegalovirus infection in relation to gestational age. J Clin Virol 52(3):244–246
3. Picone O, Vauloup-Fellous C, Cordier AG, Guitton S, Senat MV, Fuchs F, Ayoubi JM, Grangeot Keros L, Benachi A (2013) A series of 238 cytomegalovirus primary infections during pregnancy: description and outcome. Prenat Diagn 33(8):751–758
4. Bodeus M, Kabamba-Mukadi B, Zech F et al (2009) Human cytomegalovirus in utero transmission: follow-up of 524 maternal seroconversions. J Clin Virol 47:201–202
5. Born E (1955) Über frühkindliche Hirnschädigung bei Cytomegalie und ihre Abgrenzung gegenüber Toxoplasmose. Archiv für Psychiatrie und Zeitschrift Neurologie 193:557–568
6. Weisblum Y, Panet A, Haimov-Kochman R, Wolf DG (2014) Models of vertical cytomegalovirus (CMV) transmission and pathogenesis. Semin Immunopathol 36(6):615–625
7. Leruez-Ville M, Ghout I, Bussières L, Stirnemann J, Magny JF, Couderc S, Salomon LJ, Guilleminot T, Aegerter P, Benoist G, Winer N, Picone O, Jacquemard F, Ville Y (2016) In utero treatment of congenital cytomegalovirus infection with valacyclovir in a multicenter, open-label, phase II study. Am J Obstet Gynecol 215(4):462.e1–462.e10
8. Rawlinson WD, Hamilton ST, van Zuylen WJ (2016) Update on treatment of cytomegalovirus infection in pregnancy and of the newborn with congenital cytomegalovirus. Curr Opin Infect Dis 29(6):615–624
9. Revello MG, Lazzarotto T, Guerra B, Spinillo A, Ferrazzi E, Kustermann A, Guaschino S, Vergani P, Todros T, Frusca T, Arossa A, Furione M, Rognoni V, Rizzo N, Gabrielli L, Klersy C, Gerna G, CHIP Study Group (2014) A randomized trial of hyperimmune globulin to prevent congenital cytomegalovirus. N Engl J Med 370(14):1316–1326
10. Nigro G, Capretti I, Manganello AM, Best AM, Adler SP (2015) Primary maternal cytomegalovirus infections during pregnancy: association of CMV hyperimmune globulin with gestational age at birth and birth weight. J Matern Fetal Neonatal Med 28(2):168–171
11. Rawlinson WD, Boppana SB, Fowler KB, Kimberlin DW, Lazzarotto T, Alain S, Daly K, Doutré S, Gibson L, Giles ML, Greenlee J, Hamilton ST, Harrison GJ, Hui L, Jones CA, Palasanthiran P, Schleiss MR, Shand AW, van Zuylen WJ (2017) Congenital cytomegalovirus infection in pregnancy and the neonate: consensus recommendations for prevention, diagnosis, and therapy. Lancet Infect Dis 17(6):e177–e188
12. Nigro G, Adler SP, La Torre R, Best AM (2005) Congenital Cytomegalovirus Collaborating Group: passive immunization during pregnancy for congenital cytomegalovirus infection. N Engl J Med 353(13):1350–1362
13. Hamprecht K, Kagan KO, Goelz R (2014) Hyperimmune globulin to prevent congenital CMV infection. N Engl J Med 370(26):2543
14. Buxmann H, Stackelberg OM, Schlößer RL, Enders G, Gonser M, Meyer-Wittkopf M, Hamprecht K, Enders M (2012) Use of cytomegalovirus hyperimmunoglobulin for prevention of congenital cytomegalovirus disease: a retrospective analysis. J Perinat Med 40(4):439–446
15. Feldman B, Yinon Y, Tepperberg Oikawa M, Yoeli R, Schiff E, Lipitz S (2011) Pregestational, periconceptional, and gestational primary maternal cytomegalovirus infection: prenatal diagnosis in 508 pregnancies. Am J Obstet Gynecol 205(4):342.e1-6
16. Giannattasio A, Di Costanzo P, Milite P, De Martino D, Capone E, Romano A, Bravaccio C, Capasso L, Raimondi F (2017) Is lenticulostriated vasculopathy an unfavorable prognostic finding in infants with congenital cytomegalovirus infection? J Clin Virol 91:31–35
17. Bilavsky E, Schwarz M, Pardo J, Attias J, Levy I, Haimi-Cohen Y, Amir J (2015) Lenticulostriated vasculopathy is a high-risk marker for hearing loss in congenital cytomegalovirus infections. Acta Paediatr 104(9):e388–e394
18. Pass RF, Fowler KB, Boppana SB, Britt WJ, Stagno S (2006) Congenital cytomegalovirus infection following first trimester maternal infection: symptoms at birth and outcome. J Clin Virol 35(2):216–220